The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ikonics Corp

Nasdaq: IKNX
Last

(U.S.) $11.05

Today's change0.00 -0.04%
Updated August 30 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Ikonics Corp

Nasdaq: IKNX
Last

(U.S.) $11.05

Today's change0.00 -0.04%
Updated August 30 4:00 PM -4GMT. Delayed by at least 15 minutes.

Ikonics Corp down slightly

Ikonics Corp closed down just (U.S.)$0.00 Tuesday to (U.S.)$11.05. Over the last five days, shares have gained 0.36%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 19.21% during the last year.

Key company metrics

  • Open(U.S.) $11.12
  • Previous close(U.S.) $11.05
  • High(U.S.) $11.12
  • Low(U.S.) $11.05
  • Bid / Ask(U.S.) $0.00 / (U.S.) $15.36
  • YTD % change-1.25%
  • Volume656
  • Average volume (10-day)795
  • Average volume (1-month)1,470
  • Average volume (3-month)2,495
  • 52-week range(U.S.) $9.76 to (U.S.) $13.99
  • Beta0.19
  • Trailing P/E122.22×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.09
Updated August 30 4:00 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+1.04%

Based on its net profit margin of 1.04%, Ikonics Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.02%Sector:Basic MaterialsIndustry:Chemicals - Specialty

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue4455
Total other revenue--------
Total revenue4455
Gross profit2122
Total cost of revenue3333
Total operating expense4444
Selling / general / administrative1111
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income0000
Interest income (expense), net non-operating0------
Gain (loss) on sale of assets--------
Other--------
Income before tax0000
Income after tax0000
Income tax, total0000
Net income0000
Total adjustments to net income--------
Net income before extra. items0000
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items0000
Inc. avail. to common incl. extra. items0000
Diluted net income0000
Dilution adjustment--------
Diluted weighted average shares2222
Diluted EPS excluding extraordinary itemsvalue per share0.02-0.100.110.06
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.02-0.100.110.06